Quality-of-Life Considerations During Treatment for Metastatic EGFR-Positive NSCLC

Lynn Abbott-McCloud articulates that quality of life extends well beyond clinical or medical definitions: it encompasses life quality in its fullest sense, including whether a patient has the energy to pick up a grandchild after a karate class. Fatigue and gastrointestinal side effects have specific real-world manifestations beyond their clinical descriptions: fatigue means slowing down in life and becoming a different person, while gastrointestinal issues mean being unable to attend social events for fear of needing a bathroom. These nuances are often underappreciated in clinical discussions.

Elizabeth Dennis confirms that quality-of-life discussions should be a component of nearly every clinical visit, beginning at diagnosis and continuing through treatment, disease progression, and all transitions in care. Quality of life encompasses the physical, emotional, and financial dimensions of a cancer diagnosis, all of which shift significantly and continuously. Proactive assessment of these domains, not just the physical findings of the clinic encounter, allows care teams to make treatment modifications including dose reductions, dose delays, addition of supportive medications, palliative care referrals, social work engagement, and mental health referrals when indicated.

Dr. Konduri reinforces that while treatment efficacy is the primary goal, maintaining quality of life enables patients to sustain treatment over time and continue experiencing its benefits. The two objectives are not in tension but rather are interdependent.